The alterations of mouse plasma proteins during septic development

Journal of Proteome Research

Volumn 6, Issue 7, 2007, Pages 2812-2821

  Ren, Yan ^a,b   Wang, Jiandong ^c   Xia, Ji ^a,b   Jiang, Chaoguang ^c   Zhao, Kang ^a,b   Li, Rong ^c   Xu, Ningzhi ^a,b   Xu, Yingxin ^c   Liu, Siqi ^a,b,d  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Beijing Proteomics Institute   (China)

^c Military General Hospital   (China)

^d University of Louisville School of Medicine   (United States)

Author keywords

Cecal ligation and puncture (CLP); Glycoprotein; Matrix assisted laser desorption ionization time of flight (MALDI TOF) mass spectrometry; Plasma; Sepsis; Two dimensional electrophoresis (2 DE)

Indexed keywords

GLYCAN DERIVATIVE; OLIGOSACCHARIDE; PLASMA PROTEIN; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; DISEASE COURSE; GLYCOSYLATION; LIGATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PUNCTURE; SEPSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCOSYLATION; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PROTEOMICS; SEPSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34547171676     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070047k     Document Type: Article

References (42)

1. Martin, G. S.; Mannino, D. M.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2000, 348, 1546-1554.
2. Parrish, W.; Ulloa, L. High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol. Biol. 2007, 361, 145-162.
3. Riedemann, N. C.; Guo, R. F.; Ward, P. A. The enigma of sepsis. J. Clin. Invest. 2003, 112(4), 460-467.
4. Takala, A.; Nupponen, I.; Kylanpaa-Back, M. L.; Repo, H. Markers of inflammation in sepsis. Ann. Med. 2002, 34(7-8), 614-623.
5. Hopf, H. W. Molecular diagnostics of injury and repair responses in critical illness: What is the future of "monitoring" in the intensive care unit? Crit. Care Med. 2003, 31(8), S518-S523.
6. Wheeler, A. P.; Bernard, G. R. Treating patients with severe sepsis. N. Engl. J. Med. 1999, 340(3), 207-214.
7. Moshage, H. Cytokines and the hepatic acute phase response. J. Pathol. 1997, 181(3), 257-266.
8. Antonelli, M. Sepsis and septic shock: pro-inflammatory or antiinflammatory state? J. Chemother. 1999, 11(6), 536-540.
9. Rittirsch, D.; Hoesel, L. M.; Ward, P. A. The disconnect between animal models of sepsis and human sepsis. J. Leukoc. Biol. 2007, 81(1), 137-143.
10. De Maio, A.; Torres, M. B.; Reeves, R. H. Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 2005, 23(1), 11-17.
11. Heuer, J. G.; Sharma, G. R.; Gerlitz, B.; Zhang, T.; Bailey, D. L.; Ding, C.; Berg, D. T.; Perkins, D.; Stephens, E. J.; Holmes, K. C.; Grubbs, R. L.; Fynboe, K. A.; Chen, Y. F.; Grinnell, B.; Jakubowski, J. A. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit. Care Med. 2004, 32(7), 1570-1578.
12. Enoh, V. T.; Fairchild, C. D.; Lin, C. Y.; Varma, T. K.; Sherwood, E. R. Differential effect of imipenem treatment on wild-type and NK cell-deficient CD8 knockout mice during acute intraabdominal injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290(3), R685-R693.
13. Vitzthum, F.; Behrens, F.; Anderson, N. L.; Shaw, J. H. Proteomics: from basic research to diagnostic application. A review of requirements & needs. J. Proteome Res. 2005, 4(4), 1086-1097.
14. Wu, X.; Qian, G.; Zhao, Y.; Xu, D. LBP inhibitory peptide reduces endotoxin-induced macrophage activation and mortality. Inflamm. Res. 2005, 54(11), 451-457.
15. Blanco, L. E.; de Serres, F. J.; Fernandez-Bustillo, E.; Kassam, D. A.; Arbesu, D.; Rodriguez, C.; Torre, J. C. Alpha1-Antitrypsin and fibromyalgia: new data in favour of die inflammatory hypothesis of fibromyalgia. Med. Hypotheses 2005, 64(4), 759-69.
16. Suzuki, K.; Namiki, H. Serum hemopexin: suppressive effect on neutrophil functions and prospect of clinical application to autoimmune diseases. Nippon. Rinsho. 2004, 62(3), 577-586.
17. Sainz, I. M.; Isordia-Salas, I.; Castaneda, J. L.; Agelan, A.; Liu, B.; DeLa Cadena, R. A.; Pixley, R. A.; Adam, A.; Sartor, R. B.; Colman, R. W. Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis. Arthritis Rheum. 2005, 52(8), 2549-2552.
18. Hochepied, T.; Berger, F. G.; Baumann, H.; Libert, C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003, 14(1), 25-34.
19. Fournier, T.; Medjoubi-N, N.; Porquet, D. Alpha-1-acid glycoprotein. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482(1-2), 157-171.
20. Szalai, A. J.; van Ginkel, F. W.; Wang, Y.; McGhee, J. R.; Volanakis, J. E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. J. Immunol. 2000, 165(2), 1030-1035.
21. Garcia de Frutos, P.; Hardig, Y.; Dahlback, B. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 1995, 270(45), 2650-2655.
22. Navab, M.; Anantharamaiah, G. M.; Fogelman, A. M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 2005, 15(4), 158-161.
23. Marks, R. M.; Todd, R. F., III; Ward, P. A. Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 1989, 339, 314-317.
24. O'Donnell, L. C.; Druhan, L. J.; Avalos, B. R. Molecular characterization and expression analysis of leucine-rich alpha-2 glycoprotein, a novel marker of granulocytic differentiation. J. Leukoc. Biol. 2002, 72, 478-485.
25. Hubertus, P. J.; Ian, D.; Simon, P. H. Fetuin/a2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin. Sci. 2003, 105, 273-278.
26. Gericke, B.; Raila, J.; Sehouli, J.; Haebel, S.; Konsgen, D.; Mustea, A.; Schweigert, F. J. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer 2005, 5, 133.
27. Yang, Z.; Hancock, W. S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 2004, 1053, 79-88.
28. Suzuki, T.; Park, H.; Lennarz, W. J. Cytoplasmic peptide:N-glycanase (PNGase) in eukaryotic cells: occurrence, primary structure, and potential functions. FASEB J. 2002, 16(7), 635-641.
29. Bengmark, S. Modulation by enteral nutrition of the acute phase response and immune functions. Nutr. Hosp. 2003, 18(1), 1-5.
30. Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340(6), 448-454.
31. Gianazza, E.; Eberini, I.; Villa, P.; Fratelli, M.; Pinna, C.; Wait, R.; Gemeiner, M.; Miller, I. Monitoring the effects of drug treatment in rat models of disease by serum protein analysis. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2002, 771(1-2), 107-130.
32. Brinkman-van der Linden, E. C.; van Ommen, E. C.; van Dijk, W. Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis (x) groups. Glycoconj. J. 1996, 13(1), 27-31.
33. Bierhuizen, M. F.; De Wit, M.; Covers, C. A.; Ferwerda, W.; Koeleman, C.; Pos, O.; Van Dijk, W. Glycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation. Eur. J. Biochem. 1988, 175(2), 387-394.
34. van Dijk, W.; Pos, O.; van der Stelt, M. E.; Moshage, H. J.; Yap, S. H.; Dente, L.; Baumann, P.; Eap, C. B. Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice. Biochem J. 1991, 276, 343-347.
35. Bories, P. N.; Feger, J.; Benbernou, N.; Rouzeau, J. D.; Agneray, J.; Durand, G. Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity. Inflammation 1990, 14(3), 315-323.
36. Williams, J. P.; Weiser, M. R.; Pechet, T. T.; Kobzik, L.; Moore, F. D., Jr.; Hechtman, H. B. Alpha 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat. Am. J. Physiol. 1997, 273, G1031-G1035.
37. Ma, Z. H.; Ma, Q. Y.; Wang, L. C.; Sha, H. C.; Wu, S. L.; Zhang, M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflammation Res. 2005, 54(12), 522-527.
38. Le, P. T.; Muller, M. T.; Mortensen, R. F. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J. Immunol. 1982, 129(2), 665-672.
39. Ylonen, A.; Helin, J.; Bogwald, J.; Jaldcola, A.; Rinne, A.; Kalkkinen, N. Purification and characterization of novel kininogens from spotted wolffish and Atlantic cod. Eur. J. Biochem. 2002, 269(11), 2639-2646.
40. Muller-Esterl, W.; Iwanaga, S.; Nakanishi, S. Kininogens revisited. Trends Biol. Sci. 1986, 11, 336-339.
41. Espinola, R. G.; Uknis, A.; Sainz, I. M.; Isordia-Salas, I.; Pixley, R.; DeLa Cadena, R.; Long, W.; Agelan, A.; Gaughan, J.; Adam, A.; Colman, R. W. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am. J. Pathol. 2004, 165(3), 969-976.
42. Ylonen, A.; Kalkkinen, N.; Saarinen, J.; Bogwald, J.; Helin, J. Glycosylation analysis of two cysteine proteinase inhibitors from Atlantic salmon skin: di-O-acetylated sialic acids are the major sialic acid species on N-glycans. Glycobiology 2001, 11(7), 523-531.